Wellcome Sanger Institute
Reykjavik, Iceland
Sigurgeir Olafsson did his PhD at the Wellcome Sanger Institute under the supervision of Drs Carl Anderson and Peter Campbell. His work has focused on somatic mutations in non-neoplastic, chronic inflammatory diseases, including inflammatory bowel disease and psoriasis.
Disclosure information not submitted.
Friday, November 11, 2022
10:55 AM – 11:20 AM Eastern Time
